Discontinuities and Vector-Borne Diseases in Urban Areas
Vector-borne diseases (dengue, Zika, chikungunya) are an important public health issue. Understanding their transmission dynamics remains a major challenge at the sub-urban level. Indeed, environmental heterogeneities, variations in vector densities and daily mobility hinder […]
Pasteur International Center for Research on Emerging Infectious Diseases
We established an Emerging Infectious Disease Research Center in Southeast Asia and West/Central Africa with an inter-continental one-health approach designed to improve the capacity to respond rapidly and effectively to outbreaks. We built on […]
DENCLIM – Effects of climate change and variability on community vulnerability and exposure to dengue in South East Asia. Research Council of Norway. (2018-2021).
Collaborative project: Norwegian University of Life Sciences, Khon Kaen University Thailand, Asian Institute of Technology Thailand, University of Health Sciences, Laos, Baldwin Wallace University, US, Institute Pasteur Paris France, University of Umeå, Sweden. Budget […]
ECOnomic development, ECOsystem Modifications, and emerging infectious diseases Risk Evaluation (ECOMORE 2).
The ECOMORE 2 Project, funded by Agence Française de Dévéloppement, aims to guide economic development initiatives in 5 countries belonging to the Southeast Asia region (Cambodia, Vietnam, Lao PDR, Myanmar and the Philippines), in […]
DENFREE consortium – Dengue Framework for Resisting Epidemics in Europe
The main objective of the programme is to focus on finding key factors determining dengue transmission and dynamics in order to develop new tools and strategies for controlling dengue transmission. We will estimate the […]
LeiSHield – A new collaborative action to determine prevalence, anticipate emergence and assess urbanization of cutaneous and visceral leishmaniasis in LeishRIIP partner countries
Protozoan parasites of the genus Leishmania generate severe human diseases termed Leishmaniases. Due to their frequency and the severity of certain clinical forms, these diseases represent a major public health problem and limit the […]
2023Tocilizumab treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants., iScience 2023 Feb; (): 106124.
2023Efficacy Assessment of Autodissemination Using Pyriproxyfen-Treated Ovitraps in the Reduction of Dengue Incidence in Parañaque City, Philippines: A Spatial Analysis., Trop Med Infect Dis 2023 Jan; 8(1): .
2022Considering waning immunity to better explain dengue dynamics., Epidemics 2022 Oct; 41(): 100630.
2022Reconstructing long-term dengue virus immunity in French Polynesia., PLoS Negl Trop Dis 2022 Oct; 16(10): e0010367.
2022Viral transmissibility of SARS-CoV-2 accelerates in the winter, similarly to influenza epidemics., Am J Infect Control 2022 Sep; 50(9): 1070-1076.
2022Importance of Public Transport Networks for Reconciling the Spatial Distribution of Dengue and the Association of Socio-Economic Factors with Dengue Risk in Bangkok, Thailand., Int J Environ Res Public Health 2022 08; 19(16): .
2022Association between growth of the SARS-CoV-2 epidemic and increased coughing rate in cold temperatures: surveillance in Hokkaido, Japan., BMJ Open 2022 Mar; 12(3): e051534.
2022Assessing Entomological and Epidemiological Efficacy of Pyriproxyfen-Treated Ovitraps in the Reduction of Aedes Species: A Quasi-Experiment on Dengue Infection Using Saliva Samples., Int J Environ Res Public Health 2022 Mar; 19(5): .
2022Epidemiological profile of dengue in Champasak and Savannakhet provinces, Lao People’s Democratic Republic, 2003-2020., Western Pac Surveill Response J 2022 ; 13(4): 1-13.
2022[To stick or not to stick: A Plasmodium falciparum adaptive strategy to persist during the dry season]., Med Sci (Paris) 2022 01; 38(1): 9-12.
+View full list of publications